832 Results

People

  1. Pfister
    Pfister
  2. Lee
    Lee
  3. Sherman
    Sherman
  4. Riaz
    Riaz
  5. Dunn
    Dunn
  6. Wong
    Wong
  7. Ho
    Ho
  8. McBride
    McBride
  9. Shah
    Shah
  10. Tsai
    Tsai

Groups

  1. Head and Neck Service (832)
  2. Solid Tumor Oncology Division (832)
  3. Department of Medicine (826)
  4. Surgery (358)
  5. Radiation Oncology, Department of (310)
  6. Survivorship Research (310)
  7. Center for Pancreatic Cancer Research (173)
  8. Epidemiology and Biostatistics (162)
  9. Weinberg Fellows (161)
  10. Department of Pathology and Laboratory Medicine (155)
  1. "Head and Neck Service"
Formats
  1. Journal Article (407)
  2. Meeting Abstract (360)
  3. Book Section (20)
  4. Review (19)
  5. Editorial (7)
  6. Guidelines (7)
  7. Research Letter (6)
  8. Correspondence (3)
  9. Book Whole (1)
  10. Conference Paper (1)
  11. Miscellaneous (1)
Groups
  1. Head and Neck Service (832)
  2. Solid Tumor Oncology Division (832)
  3. Department of Medicine (826)
  4. Surgery (358)
  5. Radiation Oncology, Department of (310)
  6. Survivorship Research (310)

More Groups

People
  1. David Pfister (389)
  2. Eric Sherman (339)
  3. Nancy Lee (266)
  4. Alan Ho (238)
  5. Nadeem Riaz (159)
  6. Lara Dunn (141)

More People

Years
  1. 2025 (12)
  2. 2024 (72)
  3. 2023 (55)
  4. 2022 (57)
  5. 2021 (58)
  6. 2020 (66)

More Years

Publications
  1. Journal of Clinical Oncology (205)
  2. International Journal of Radiation Oncology, Biology, Physics (140)
  3. Annals of Oncology (43)
  4. Cancer (33)
  5. Head & Neck (28)
  6. Journal of the National Comprehensive Cancer Network (28)

More Publications

Publishers
  1. American Society of Clinical Oncology (219)
  2. Elsevier Inc. (176)
  3. Wiley Blackwell (55)
  4. Oxford University Press (53)
  5. American Association for Cancer Research (46)
  6. Harborside Press (28)

More Publishers

Results (832)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: A multicentre, open-label, phase 2 trial
    Journal Article

    Schwartz, G. K.; Tap, W. D.; Qin, L. X.; Livingston, M. B.; Undevia, S. D.; Chmielowski, B.; Agulnik, M.; Schuetze, S. M.; Reed, D. R.; Okuno, S. H.; more...
    Lancet Oncology (2013)

    Fulltext@MSK | Save
  • Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
    Journal Article

    Ho, A. L.; Grewal, R. K.; Leboeuf, R.; Sherman, E. J.; Pfister, D. G.; Deandreis, D.; Pentlow, K. S.; Zanzonico, P. B.; Haque, S.; Gavane, S.; more...
    New England Journal of Medicine (2013)

    Fulltext@MSK | Save
  • Should cetuximab replace cisplatin for definitive chemoradiotherapy in locally advanced head and neck cancer?
    Journal Article

    Riaz, N.; Sherman, E. J.; Fury, M.; Lee, N.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer
    Journal Article

    Isham, C. R.; Bossou, A. R.; Negron, V.; Fisher, K. E.; Kumar, R.; Marlow, L.; Lingle, W. L.; Smallridge, R. C.; Sherman, E. J.; Suman, V. J.; more...
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • A phase II study of temsirolimus/sorafenib in patients with radioactive iodine (RAI)-refractory thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fury, M. G.; Baxi, S. S.; Haque, S.; Korte, S. H.; Smith-Marrone, S.; Xiao, H.; Ghossein, R. A.; Fagin, J. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Efficacy of concurrent cetuximab (C225) versus 5-fluorouracil/carboplatin (5FU/CBDCA) or cisplatin (CDDP) with intensity-modulated radiation therapy (IMRT) for locally advanced head and neck cancer (LAHNSCC)
    Meeting Abstract

    Shapiro, L. Q.; Sherman, E. J.; Koutcher, L.; Setton, J.; Zhang, Z.; Shi, W.; Rao, S. S.; Fury, M. G.; Wolden, S. L.; Kraus, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Reacquisition of RAI uptake in RAI-refractory metastatic thyroid cancers by pretreatment with the MEK inhibitor selumetinib
    Meeting Abstract

    Ho, A. L.; Leboeuf, R.; Grewal, R. K.; Sherman, E. J.; Deandreis, D.; Pentlow, K. S.; Tuttle, R. M.; Fury, M. G.; Ricarte-Filho, J. C. M.; Pfister, D. G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase I study of everolimus (E) plus weekly cisplatin (CDDP) plus intensity-modulated radiation therapy (IMRT) in head and neck (HN) cancer
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Ho, A. L.; Rao, S. S.; Shen, R.; Korte, S. H.; Lisa, D. M.; Ganly, I.; Katabi, N.; Patel, S. G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Competing causes of mortality in long-term survivors of head and neck cancer
    Meeting Abstract

    Baxi, S. S.; Pinheiro, L. C.; Patil, S.; Pfister, D. G.; Oeffinger, K. C.; Elkin, E. B.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Limited absorption of low dose 10µg intravaginal 17-β Estradiol (Vagifem®) in postmenopausal women with breast cancer on aromatase inhibitors
    Meeting Abstract

    Goldfarb, S. B.; Dickler, M.; Dnistrian, A.; Patil, S.; Dunn, L.; Chang, K.; Berkowitz, A.; Tucker, N.; Carter, J.; Barakat, R.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save